Client is a biopharmaceutical company that develops medicines in areas of unmet need.
Issues related to reforming and increasing transparency within the 340B Drug Pricing Program. S.1375/H.R. 830 HELP Copays Act Access and reimbursement of drugs in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
ALANNA TEMME JOHN MCMANUS ALANNA TEMME (LD, Rep. Jon Porter) JOHN MCMANUS
LD, Rep. Jon Porter